Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report
- 1 October 2000
- journal article
- review article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 19 (1-2) , 67-74
- https://doi.org/10.1016/s1386-6532(00)00091-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa RicaJNCI Journal of the National Cancer Institute, 2000
- Chimeric Virus-like Particles of the Human Papillomavirus Type 16 (HPV 16) as a Prophylactic and Therapeutic VaccineArchives of Medical Research, 1999
- Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor modelProceedings of the National Academy of Sciences, 1998
- Strategies for immunoprophylaxis and immunotherapy of papillomavirusesClinics in Dermatology, 1997
- Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic ImmunizationVirology, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM,and mucosal IgA antibodiesVirology, 1995
- Human Papillomavirus Types 6 and 11 Have Antigenically Distinct Strongly Immunogenic Conformationally Dependent Neutralizing EpitopesVirology, 1994
- Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.Proceedings of the National Academy of Sciences, 1992
- The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopesVirology, 1991